Cancer statistics in China, 2015

Chen, Wanqing; Zheng, Rongshou; Baade, Peter D.; Zhang, Siwei; Zeng, Hongmei; Bray, Freddie; Jemal, Ahmedin; Yu, Xue Qin; He, Jie

doi:10.3322/caac.21338

Cited by 17,038Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionEconomic and Financial Impacts of Cancer

Cancer statistics in China, 2015

Open access

Chen, Wanqing, Zheng, Rongshou, Baade, Peter D., Zhang, Siwei, Zeng, Hongmei, Bray, Freddie, Jemal, Ahmedin, Yu, Xue Qin +1 more·2016·CA: A Cancer Journal for Clinicians

DOI 10.3322/caac.21338

Open this paper in CoChat — free account Open PDF

Abstract

With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high‐quality data from an additional number of population‐based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population‐based cancer registries (2009‐2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000‐2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age‐standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (−1.4% per year; P < .05) and females (−1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations. CA Cancer J Clin 2016;66:115–132. © 2016 American Cancer Society.

Integrity signals

Registry

Crossref · 10.3322/caac.21338

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Thyroid carcinomas are more prevalent among women.
“Thyroid carcinomas are more prevalent among women.”
From Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells (2017) · cites this paper as [4]

Global cancer statistics
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,708 · see citing works
Self-citation
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,858 · see citing works
Self-citation
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H.-R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 22,207 · see citing works
Self-citation
China statistical yearbook
中華人民共和国国家統計局 (1988) · Medical Entomology and Zoology · Cited by 12,443 · see citing works
Cancer statistics, 2015
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,854 · see citing works
Self-citation
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404 · see citing works
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064 · see citing works
Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485 · see citing works
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936 · see citing works
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990 · see citing works
Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614 · see citing works
Self-citation
Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in Children
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883 · see citing works
Global Burden of Human Papillomavirus and Related Diseases
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet‐Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.055 · Cited by 1,642 · see citing works
Self-citation
The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General, 2014Us Department of Health and Human Services Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for: Critique
Courtney, R. J. (2015) · Drug and Alcohol Review · doi:10.1111/dar.12309 · Cited by 1,438 · see citing works
Early appraisal of China's huge and complex health-care reforms
Yip, W. C.-M., Hsiao, W. C., Chen, W., Hu, S., Ma, J., & Maynard, A. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61880-1 · Cited by 1,155 · see citing works
Self-citation
Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination
Liang, X., Bi, S., Yang, W., Wang, L., Cui, G., Cui, F., Zhang, Y., Liu, J., Gong, X.-H., Chen, Y., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.048 · Cited by 982 · see citing works
Kim H‐J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351
Kim, H. (2001) · Statistics in Medicine · doi:10.1002/sim.811 · Cited by 885 · see citing works
The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends
Youlden, D. R., Cramb, S. M., & Baade, P. D. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31818020eb · Cited by 817 · see citing works
Self-citation
International patterns and trends in thyroid cancer incidence, 1973–2002
Aschebrook‐Kilfoy, B., Zheng, T., Holford, T. R., Han, X., Ward, M. H., Sjödin, A., Zhang, Y., Bai, Y., Zhu, C., Guo, G. L., et al. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9260-4 · Cited by 710 · see citing works
Global cancer surgery: delivering safe, affordable, and timely cancer surgery
Sullivan, R. J., Alatise, O. I., Anderson, B. O., Audisio, R. A., Autier, P., Aggarwal, A. K., Balch, C. M., Brennan, M. F., Dare, A. J., Dcruz, A. K., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00223-5 · Cited by 706 · see citing works
Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness
Bray, F., & Parkin, D. M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.032 · Cited by 634 · see citing works
Self-citation
Cancer survival in C hina, 2003–2005: A population‐based study
Zeng, H., Zheng, R., Guo, Y., Zhang, S., Zou, X., Wang, N., Zhang, L., Tang, J., Chen, J., Wei, K., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29227 · Cited by 622 · see citing works
Self-citation
Annual report on status of cancer in China, 2010
Wanqing, Chen, Rongshou, Zheng, Z., Siwei, Zhang, Ping, P., Zhao, Hongmei, Zeng, et al. (2014) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 565 · see citing works
Preventing chronic diseases in China
Wang, L., Kong, L., Wu, F., Bai, Y., & Burton, R. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67344-8 · Cited by 558 · see citing works
Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness
Parkin, D. M., & Bray, F. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.033 · Cited by 536 · see citing works
Self-citation
The Increasing Incidence of Thyroid Cancer: The Influence of Access to Care
Morris, L. G. T., Sikora, A. G., Tosteson, T. D., & Davies, L. (2013) · Thyroid · doi:10.1089/thy.2013.0045 · Cited by 520 · see citing works
Challenges to effective cancer control in China, India, and Russia
Goss, P. E., Strasser‐Weippl, K., Bychkovsky, B., Fan, L., Li, J., Chávarri-Guerra, Y., Liedke, P. E. R., Pramesh, C. S., Badovinac-Črnjević, T., Sheikine, Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70029-4 · Cited by 496 · see citing works
Self-citation
Environmental health in China: progress towards clean air and safe water
Zhang, J. J., Mauzerall, D. L., Zhu, T., Liang, S., Ezzati, M., & Remais, J. V. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60062-1 · Cited by 465 · see citing works
Estimates of Cancer Incidence in China for 2000 and Projections for 2005
Yang, L., Parkin, D. M., Ferlay, J., Li, L., & Chen, Y. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.243.14.1 · Cited by 463 · see citing works
Prevalence of Smoking in China in 2010
Li, Q., Hsia, J., & Yang, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1102459 · Cited by 454 · see citing works
International epidemiology of prostate cancer: Geographical distribution and secular trends
Baade, P. D., Youlden, D. R., & Krnjacki, L. J. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700511 · Cited by 446 · see citing works
Self-citation
Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies
Chen, Z., Peto, R., Zhou, M., Iona, A., Smith, M., Yang, L., Guo, Y., Chen, Y., Bian, Z., Lancaster, G., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00340-2 · Cited by 430 · see citing works
Epidemiology of lung cancer in C hina
Chen, W., Zheng, R., Zeng, H., & Zhang, S. (2014) · Thoracic Cancer · doi:10.1111/1759-7714.12169 · Cited by 428 · see citing works
Self-citation
Annual report on status of cancer in China, 2010.
Chen, W., Zheng, R., Zhang, S., Zhao, P., Zeng, H., Zou, X., & He, J. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2014.01.08 · Cited by 378 · see citing works
Self-citation
The incidence and mortality of major cancers in China, 2012
Chen, W., Zheng, R., Zeng, H., & Zhang, S. (2016) · 癌症：英文版 · doi:10.1186/s40880-016-0137-8 · Cited by 355 · see citing works
Self-citation
Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin’s lymphoma: evidence from a meta-analysis
Chen, S., Zhu, J., Wang, F., Huang, S.-Y., Xue, W., Cui, Z., He, J., & Jia, W.-H. (2015) · 癌症：英文版 · doi:10.1186/s40880-015-0001-2 · Cited by 352 · see citing works
Self-citation
Mortality registration and surveillance in China: History, current situation and challenges
Yang, G., Hu, J., Rao, K. Q., Ma, J., Rao, C., & López, A. D. (2005) · Population Health Metrics · doi:10.1186/1478-7954-3-3 · Cited by 341 · see citing works
Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China
Wei, W., Chen, Z., He, Y., Feng, H., Hou, J., Lin, D., Li, X., Cui-lan, G., Li, S.-S., Wang, G., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.0423 · Cited by 329 · see citing works
Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours
Brito, J. P., Morris, J. C., & Montori, V. M. (2013) · BMJ · doi:10.1136/bmj.f4706 · Cited by 323 · see citing works
Summarizing indices for comparison of cancer incidence data
Doll, R., & Cook, P. J. (1967) · International Journal of Cancer · doi:10.1002/ijc.2910020310 · Cited by 292 · see citing works
Prostate cancer in Asian men
Ito, K. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.42 · Cited by 274 · see citing works
The road to effective tobacco control in China
Yang, G., Wang, Y., Wu, Y., Yang, J., & Wan, X. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60174-x · Cited by 269 · see citing works
Prevention and management of lung cancer in China
Hong, Q., Wu, G., Qian, G., Hu, C., Zhou, J., Chen, L., Li, W., Li, S.-Y., Wang, K., Wang, Q., et al. (2015) · Cancer · doi:10.1002/cncr.29584 · Cited by 267 · see citing works
Report of cancer incidence and mortality in China, 2010.
Chen, W., Zheng, R., Zhang, S., Zhao, P., Zeng, H., & Zou, X. (2014) · PubMed Central · doi:10.3978/j.issn.2305-5839.2014.04.05 · Cited by 254 · see citing works
Self-citation
Evaluation of Risk Factors for Nasopharyngeal Carcinoma in High-Risk Nasopharyngeal Carcinoma Families in Taiwan
Yang, X. R., Diehl, S. R., Pfeiffer, R. M., Chen, C., Hsu, W.-L., Dosemeci, M., Cheng, Y., Sun, B., Goldstein, A. M., Hildesheim, A., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0680 · Cited by 249 · see citing works
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study
Group20, T. I. M. 1. W., Walters, S., Maringe, C., Butler, J., Rachet, B., Barrett-Lee, P. J., Bergh, J. C. S., Boyages, J., Christiansen, P., Lee, M., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.6 · Cited by 244 · see citing works
Estimation and projection of the national profile of cancer mortality in China: 1991–2005
Yang, L., Parkin, D. M., Li, L. D., Chen, Y. D., & Bray, F. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601813 · Cited by 233 · see citing works
Self-citation
The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival
Vostakolaei, F. A., Karim‐Kos, H. E., Janssen-Heijnen, M. L. G., Visser, O. J., Verbeek, A. L. M., & Kiemeney, L. A. L. M. (2010) · European Journal of Public Health · doi:10.1093/eurpub/ckq120 · Cited by 231 · see citing works
Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: A pooled analysis of 17 population‐based studies
Zhao, F., Lewkowitz, A. K., Hu, S., Chen, F., Li, L., Zhang, Q., Wu, R., Li, C., Wei, L., Xu, A., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27571 · Cited by 209 · see citing works
Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all
Harford, J. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70273-4 · Cited by 190 · see citing works
Tobacco smoking in China: Prevalence, disease burden, challenges and future strategies
Zhang, J., Ou, J., & Bai, C. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02062.x · Cited by 186 · see citing works
Epidemiology of prostate cancer in the Asia-Pacific region
Baade, P. D., Youlden, D. R., Cramb, S. M., Dunn, J. C., & Gardiner, R. A. (2013) · Prostate International · doi:10.12954/pi.12014 · Cited by 183 · see citing works
Self-citation
Cancer incidence, survival and mortality: Explaining the concepts
Ellis, L., Woods, L. M., Estève, J., Eloranta, S., Coleman, M. P., & Rachet, B. (2014) · International Journal of Cancer · doi:10.1002/ijc.28990 · Cited by 161 · see citing works
The incidences and mortalities of major cancers in China, 2009
Chen, W., Zheng, R., Zhang, S., Zhao, P., Li, G., Wu, L., & He, J. (2013) · 癌症：英文版 · doi:10.5732/cjc.013.10018 · Cited by 150 · see citing works
Self-citation
Cervical Cancer Screening Among Adult Women in China, 2010
Wang, B., He, M., Chao, A., Engelgau, M. M., Saraiya, M., Wang, L., & Wang, L. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0303 · Cited by 137 · see citing works
Attributable causes of cancer in China
Wang, J., Jiang, Y., Liang, H., Li, P., Xiao, H., Ji, J., Xiang, W., Shi, J. F., Fan, Y. G., Li, L., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds139 · Cited by 119 · see citing works
Self-citation
Tobacco use among youth and adults in Mainland China: The China Seven Cities Study
Johnson, C. A., Palmer, P. H., Chou, C., Pang, Z., Zhou, D., Dong, L., Xiang, H., Yang, P., Xu, H., Wang, J., et al. (2006) · Public Health · doi:10.1016/j.puhe.2006.07.023 · Cited by 103 · see citing works
Prevalence of Smoking in China
Yang, G. (2008) · Series on contemporary China · doi:10.1142/9789812792365_0002 · Cited by 93 · see citing works
Emerging tobacco‐related cancer risks in C hina: A nationwide, prospective study of 0.5 million adults
Chen, Z., Peto, R., Iona, A., Yu, C., Chen, Y., Bian, Z., Yang, L., Zhang, W., Lu, F., Chen, J., et al. (2015) · Cancer · doi:10.1002/cncr.29560 · Cited by 91 · see citing works
Testing the equality of two dependent kappa statistics
Donner, A. P., Shoukri, M. M., Klar, N. S., & Bartfay, E. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3 · Cited by 90 · see citing works
Changes in Prevalence and Clinical Characteristics of Cervical Cancer in the People's Republic of China: A Study of 10,012 Cases From a Nationwide Working Group
Li, S., Hu, T., Lv, W., Zhou, H., Li, X., Yang, R., Yao, J., Huang, K., Chen, Z., Wang, S., et al. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0123 · Cited by 90 · see citing works
Increasing thyroid cancer incidence in Q ueensland, A ustralia 1982–2008 – true increase or overdiagnosis?
Pandeya, N., McLeod, D. S. A., Balasubramaniam, K., Baade, P. D., Youl, P., Bain, C., Allison, R., & Jordan, S. J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12724 · Cited by 71 · see citing works
Self-citation
Smoking patterns among Chinese rural-urban migrant workers.
Yang, T.-Z., Wu, J., Rockett, I., Abdullah, A., Beard, J., & Ye, J. (2009) · Public Health · doi:10.1016/j.puhe.2009.09.021 · Cited by 61 · see citing works
International rules for multiple primary cancers.
(2005) · PubMed · Cited by 60 · see citing works
Time Trends of Ovarian Cancer Incidence in China
Wang, B., Liu, S., Zheng, R., Zhang, F., Chen, W., & Sun, X. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.1.191 · Cited by 56 · see citing works
Self-citation
Monitoring and Evaluating Progress towards Universal Health Coverage in China
Meng, Q., & Xu, L. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001694 · Cited by 55 · see citing works
Time trends and age-period-cohort analyses on incidence rates of thyroid cancer in Shanghai and Hong Kong
Xie, S., Chen, J., Zhang, B., Wang, F., Li, S.-S., Xie, C., Tse, L. A., & Cheng, J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-975 · Cited by 50 · see citing works
Effectiveness of novel, lower cost molecular human papillomavirus‐based tests for cervical cancer screening in rural china
Valdez, M., Jerónimo, J., Bansil, P., Qiao, Y., Zhao, F., Chen, W., Zhang, X., Kang, L., Paul, P., Bai, P., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29877 · Cited by 50 · see citing works
Self-citation
Increased lung cancer mortality rates in the Chinese population from 1973‐1975 to 2004‐2005: An adverse health effect from exposure to smoking
Zhi, X., Zou, X., Hu, M., Jiang, Y., Jia, M., & Yang, G. (2015) · Cancer · doi:10.1002/cncr.29603 · Cited by 44 · see citing works
An age-period-cohort analysis of female breast cancer mortality from 1990–2009 in China
Li, C., Yu, C., & Wang, P. (2015) · International Journal for Equity in Health · doi:10.1186/s12939-015-0211-x · Cited by 37 · see citing works
Attributable causes of breast cancer and ovarian cancer in China: Reproductive factors, oral contraceptives and hormone replacement therapy
Li, L., Ji, J., Wang, J.-B., Niyazi, M., Qiao, Y., & Boffetta, P. (2012) · Chinese Journal of Cancer Research · doi:10.1007/s11670-012-0009-y · Cited by 35 · see citing works
Pathways to the diagnosis of thyroid cancer in New South Wales: a population-based cross-sectional study
Kahn, C., Simonella, L., Sywak, M. S., BOYAGES, S. C., Ung, O., & O’Connell, D. L. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9852-2 · Cited by 30 · see citing works
Representativeness of population-based cancer registration in China--comparison of urban and rural areas.
Li, G. L., & Chen, W. Q. (2009) · PubMed · Cited by 29 · see citing works
Self-citation
Strengthening cancer control in China
Varghese, C. V., & Shin, H. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70056-7 · Cited by 26 · see citing works
Estimation of cancer cases and deaths attributable to infection in China
Xiang, W., Shi, J., Li, P., Wang, J., Xu, L., Wei, W., Zhao, F., Qiao, Y., & Boffetta, P. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9791-y · Cited by 25 · see citing works
[Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
Li, R., Yang, J.-Y., Gong, J., Li, Y., Huang, Z.-N., Fang, K.-X., Xu, Z.-Y., Liu, C.-B., Zhao, K., & Zhuang, H. (2004) · PubMed · Cited by 23 · see citing works
Chinese Government admits existence of cancer villages
Gao, H. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70065-2 · Cited by 21 · see citing works
Cancer burden in China: a Bayesian approach
Chen, W., Armstrong, B. K., Zheng, R., Zhang, S., Yu, X. Q., & Clements, M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-458 · Cited by 15 · see citing works
Self-citation
PRIMARY LIVER CANCER : NATURAL TOXINS AND PREVENTION IN CHINA
Yu, S., Gong, C., Zhi, X.-L., & Li, J. B. (1998) · The Journal of Toxicological Sciences · doi:10.2131/jts.23.supplementii_143 · Cited by 13 · see citing works
Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites
Yu, X. Q., O’Connell, D. L., & Forman, D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602154 · Cited by 13 · see citing works
Self-citation
Tobacco and China: The worst is yet to come
Paskett, E. D., Bernardo, B. M., & Khuri, F. R. (2015) · Cancer · doi:10.1002/cncr.29600 · Cited by 7 · see citing works
Another step change for tobacco control in China?
Hu, Y., Sun, X., Yuan, Z., Dong, W., & Zhang, J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61409-x · Cited by 7 · see citing works
Balancing priorities in China's expanding health-care system
Alcorn, T. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70403-5 · Cited by 2 · see citing works

Flagged first, then by citations

2 of the 85 references couldn’t be matched to a known paper.

Sorted by citations

Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Xia, C., Dong, X., Li, H., Cao, M., Sun, D., He, S., Yang, F., Yan, X., Zhang, S., Li, N., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002108 · Cited by 3,675 · see citing works
Self-citation
Nasopharyngeal carcinoma
Chen, Y., Chan, A. T. �., Le, Q., Blanchard, P., Sun, Y. H., & Ma, J. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30956-0 · Cited by 3,157 · see citing works
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
Cao, W., Chen, H., Yu, Y., Li, N., & Chen, W. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001474 · Cited by 2,886 · see citing works
Self-citation
Cancer incidence and mortality in China, 2022
Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.01.006 · Cited by 2,379 · see citing works
Self-citation
Global burden of primary liver cancer in 2020 and predictions to 2040
Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., Laversanne, M., McGlynn, K. A., & Soerjomataram, I. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.021 · Cited by 2,197 · see citing works
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054 · see citing works
Epidemiology of Esophageal Squamous Cell Carcinoma
Abnet, C. C., Arnold, M., & Wei, W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.023 · Cited by 1,679 · see citing works
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Feng, R., Zong, Y., Cao, S., & Xu, R. (2019) · 癌症：英文版 · doi:10.1186/s40880-019-0368-6 · Cited by 1,630 · see citing works
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0422 · Cited by 1,589 · see citing works
Epidemiology and determinants of obesity in China
Pan, X., Wang, L., & Pan, A. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00045-0 · Cited by 1,567 · see citing works
Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries
Zeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J. S., Zou, X., Xia, C., Sun, K., Yang, Z., Li, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30127-x · Cited by 1,546 · see citing works
Self-citation
Epidemiology of ovarian cancer: a review
Reid Brett, M., Reid Brett, M., Permuth, J. B., Sellers Thomas, A., Permuth, J. B., & Sellers Thomas, A. (2017) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,536 · see citing works
Cancer incidence and mortality in China, 2016
Zheng, R., Sun, K., Han, B., Li, L., Chen, R., Wang, S., Li, L., Zeng, H., He, J., Wei, W., et al. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.02.002 · Cited by 1,515 · see citing works
Self-citation
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,537 · see citing works
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
Ren, Z., Xu, J., Bai, Y., Xu, A., Cang, S., Du, C., Li, Q., Lu, Y., Chen, Y., Guo, Y., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00252-7 · Cited by 1,124 · see citing works
Oesophageal cancer
Smyth, E. C., Lagergren, J., Fitzgerald, R. C., Lordick, F., Shah, M. A., Lagergren, P., & Cunningham, D. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.48 · Cited by 1,063 · see citing works
Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020
Qiu, H., Cao, S., & Xu, R. (2021) · 癌症：英文版 · doi:10.1002/cac2.12197 · Cited by 1,015 · see citing works
Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor−κB, and Up-regulating Expression of MicroRNA-21
Yang, Y. P., Weng, W., Peng, J., Hong, L., Yang, L., Toiyama, Y., Gao, R., Liu, M., Yin, M., Pan, C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.11.018 · Cited by 1,015 · see citing works
Cancer incidence and mortality in China, 2014
Chen, W., Sun, K., Zheng, R., Zeng, H., Zhang, S., Xia, C., Yang, Z., He, L., Zou, X., & He, J. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.01.01 · Cited by 1,019 · see citing works
Self-citation
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
Yang, H., Liu, H., Chen, Y., Zhu, C., Fang, W., Yu, Z., Mao, W., Xiang, J., Han, Y., Chen, Z., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.1483 · Cited by 1,003 · see citing works
Physical activity, exercise, and chronic diseases: A brief review
Anderson, E., & Durstine, J. L. (2019) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2019.08.006 · Cited by 1,071 · see citing works
The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention
Liu, Z., Jiang, Y., Yuan, H., Fang, Q., Cai, N., Suo, C., Li, J., Zhang, T., & Chen, X. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.001 · Cited by 826 · see citing works
Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
Ren, Z., Li, A., Jiang, J., Zhou, L., Yu, Z., Lu, H., Xie, H., Chen, X., Shao, L., Zhang, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315084 · Cited by 772 · see citing works
Liquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 785 · see citing works
Role of pyroptosis in inflammation and cancer
Xiang, W. D., Xie, F., Zhou, X., Wu, Y., Yan, H., Liu, T., Huang, J. S., Wang, F., Zhou, F., & Zhang, L. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00905-x · Cited by 715 · see citing works
A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks
Fang, E. F., Xie, C., Schenkel, J. A., Wu, C., Long, Q., Cui, H., Aman, Y., Frank, J., Liao, J., Zou, H., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101174 · Cited by 704 · see citing works
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Zhou, J., Sun, H., Wang, Z., Cong, W., Wang, J., Zeng, M., Yang, J.-M., Bie, P., Liu, L.-X., Wen, T., et al. (2018) · Liver Cancer · doi:10.1159/000488035 · Cited by 649 · see citing works
Self-citation
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Du, D., Liu, C., Qin, M., Zhang, X., Xi, T., Yuan, S., Hao, H., & Xiong, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.019 · Cited by 649 · see citing works
The role of TGF-β/SMAD4 signaling in cancer
Zhao, M., Mishra, L., & Deng, C.-X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23230 · Cited by 631 · see citing works
The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017
Etemadi, A., Safiri, S., Sepanlou, S. G., Ikuta, K. S., Bisignano, C., Shakeri, R., Amani, M., Fitzmaurice, C., Nixon, M. R., Abbasi, N., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30328-0 · Cited by 634 · see citing works
Global trends and predictions in hepatocellular carcinoma mortality
Bertuccio, P., Turati, F., Carioli, G., Rodriguez, T., Vecchia, C. L., Malvezzi, M., & Negri, E. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.011 · Cited by 635 · see citing works
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
Chen, X., Gole, J., Gore, A., He, Q., Lü, M., Min, J., Yuan, Z., Yang, X., Jiang, Y., Zhang, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17316-z · Cited by 637 · see citing works
Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
Zheng, P., Chen, L., Yuan, X., Luo, Q., Liu, Y., Xie, G., Ma, Y., & Shen, L. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0528-y · Cited by 630 · see citing works
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer
Han, B., Li, K., Wang, Q., Zhang, L., Shi, J., Wang, Z., Cheng, Y., He, J., Shi, Y., Zhao, Y., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.3039 · Cited by 617 · see citing works
Self-citation
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Jiang, T., Mao, Y. Q., Ma, W., Mao, Q., You, Y., Yang, X., Jiang, C., Kang, C., Li, X., Chen, L., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.024 · Cited by 605 · see citing works
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
Qin, S., Ren, Z., Meng, Z., Chen, Z., Chai, X., Xiong, J., Bai, Y., Yang, L., Zhu, H., Fang, W. J., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30011-5 · Cited by 604 · see citing works
Pancreatic cancer: A review of epidemiology, trend, and risk factors
Hu, J.-X., Zhao, C., Chen, W.-B., Liu, Q., Li, Q.-W., Lin, Y., & Gao, F. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i27.4298 · Cited by 602 · see citing works
Self-citation
Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis
Zhou, F., Zhou, J., Wang, W., Zhang, X., Ji, Y., Zhang, P., She, Z., Zhu, L., Cai, J., & Li, H. (2019) · Hepatology · doi:10.1002/hep.30702 · Cited by 589 · see citing works
The Intestinal Microbiota and Colorectal Cancer
Cheng, Y., Ling, Z., & Li, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615056 · Cited by 588 · see citing works
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 604 · see citing works
Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis
Zhang, H., Deng, T., Liu, R., Bai, M., Zhou, L., Wang, X., Li, S., Wang, X., Yang, H., Li, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15016 · Cited by 561 · see citing works
Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing
Jin, X., Chen, Y., Chen, H., Fei, S., Chen, D., Cai, X., Liu, L., Lin, B., Su, H., Zhao, L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0577 · Cited by 560 · see citing works
Global liver disease burdens and research trends: Analysis from a Chinese perspective
Xiao, J., Wang, F., Wong, N.-K., He, J., Rui, Z., Sun, R., Xu, Y., Liu, Y., Li, W., Koike, K., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.004 · Cited by 554 · see citing works
Self-citation
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China
Xu, X.-F., Xing, H., Han, J., Li, Z.-L., Lau, W.-Y., Zhou, Y.-H., Gu, W.-M., Wang, H., Chen, T.-H., Zeng, Y.-Y., et al. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2018.4334 · Cited by 532 · see citing works
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
Lü, Y., Xue, J., Deng, T., Zhou, X., Yu, K., Deng, L., Huang, M., Yi, X., Liang, M., Wang, Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0840-5 · Cited by 543 · see citing works
Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
Wang, M., Mao, C., Ouyang, L., Liu, Y., Lai, W., Liu, N., Shi, Y., Chen, L., Xiao, D., Yu, F., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0304-y · Cited by 530 · see citing works
National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data
Qi, J., Li, M., Wang, L., Hu, Y., Liu, W. Y., Long, Z., Zhou, Z., Yin, P., & Zhou, M. (2023) · The Lancet Public Health · doi:10.1016/s2468-2667(23)00211-6 · Cited by 534 · see citing works
DNA Damage, Mutagenesis and Cancer
Basu, A. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040970 · Cited by 524 · see citing works
Cancer registration in China and its role in cancer prevention and control
Wei, W., Zeng, H., Zheng, R., Zhang, S., An, L., Chen, R., Wang, S., Sun, K., Matsuda, T., Bray, F., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30073-5 · Cited by 497 · see citing works
Self-citation
Cervical cancer: Epidemiology, risk factors and screening
Zhang, S., Xu, H., Zhang, L., & Qiao, Y. (2020) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2020.06.05 · Cited by 536 · see citing works
Self-citation
Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells
Yu, J., Li, S., Qi, J., Chen, Z., Wu, Y., Guo, J., Wang, K., Sun, X., & Zheng, J. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1441-4 · Cited by 477 · see citing works
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Zhou, J., Sun, H., Wang, Z., Cong, W., Zeng, M., Zhou, W., Bie, P., Liu, L., Wen, T., Kuang, M., et al. (2023) · Liver Cancer · doi:10.1159/000530495 · Cited by 505 · see citing works
Self-citation
Epidemiology of lung cancer in China
Cao, M., & Chen, W. (2018) · Thoracic Cancer · doi:10.1111/1759-7714.12916 · Cited by 471 · see citing works
Self-citation
Cancer incidence and mortality in China, 2013.
Chen, W.-Q., Zheng, R.-S., Zhang, S.-W., Zeng, H., Xia, C., Zuo, T.-T., Yang, Z.-X., Zou, X., & He, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.024 · Cited by 403 · see citing works
Self-citation
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
Wang, F., Wei, X., Wang, F., Xu, N., Shen, L., Dai, G., Yuan, X., Chen, Y., Yang, S., Shi, J., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz197 · Cited by 456 · see citing works
Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation
Zhang, C., Li, C., Wang, Y., Xu, L., He, X., Zeng, Q., Zeng, C., Mai, F., Hu, B., & Ouyang, D. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01515-1 · Cited by 443 · see citing works
Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013
Islami, F., Chen, W., Yu, X. Q., Lortet‐Tieulent, J., Zheng, R., Flanders, W. D., Xia, C., Thun, M. J., Gapstur, S. M., Ezzati, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx342 · Cited by 439 · see citing works
Self-citation
Cancer burden of major cancers in China: A need for sustainable actions
Cao, M., He, L., Sun, D., & Chen, W. (2020) · 癌症：英文版 · doi:10.1002/cac2.12025 · Cited by 439 · see citing works
Self-citation
Clinical practice guidelines for the management of adult diffuse gliomas
Jiang, T., Nam, D., Ram, Z., Poon, W. S., Wang, J., Boldbaatar, D., Mao, Y. Q., Ma, W., Mao, Q., You, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.050 · Cited by 431 · see citing works
Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study
Li, X., Zhang, S., Zhang, Q., Wei, X., Pan, Y., Zhao, J., Xin, X., Qin, C., Wang, X., Li, J., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30762-9 · Cited by 433 · see citing works
Self-citation
circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1
Cheng, Z., Yu, C., Cui, S., Wang, H., Jin, H., Wang, C., Li, B., Qin, M., Yang, C. G., He, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11162-4 · Cited by 418 · see citing works
Self-citation
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
Tang, L., Chen, Y., Chen, C., Chen, M., Chen, N., Chen, X., Du, X., Fang, W., Feng, M., Gao, J., et al. (2021) · 癌症：英文版 · doi:10.1002/cac2.12218 · Cited by 420 · see citing works
HCAR1/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and Its Therapeutic Implications
Zhao, Y., Li, M., Yao, X., Yang, F., Lin, Z., Li, Z., Cai, K., Zhao, Y., & Luo, Z. Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108487 · Cited by 417 · see citing works
Targeting hypoxic tumor microenvironment in pancreatic cancer
Tao, J., Yang, G., Zhou, W., Qiu, J., Chen, G., Luo, W., Zhao, F., You, L., Zheng, L., Zhang, T., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01030-w · Cited by 419 · see citing works
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial
Li, J., Qin, S., Xu, R.-H., Shen, L., Xu, J., Bai, Y., Yang, L., Deng, Y., Chen, Z.-D., Zhong, H., et al. (2018) · JAMA · doi:10.1001/jama.2018.7855 · Cited by 425 · see citing works
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin, C., Yang, G., Yang, J., Ren, B., Wang, H., Chen, G., Zhao, F., You, L., Wang, W., & Zhao, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01169-7 · Cited by 415 · see citing works
Epidemiology of prostate cancer in Asian countries
Kimura, T., & Egawa, S. (2018) · International Journal of Urology · doi:10.1111/iju.13593 · Cited by 413 · see citing works
A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis
Wang, Y., Yang, L., Chen, T., Liu, X., Guo, Y., Zhu, Q., Tong, X., Yang, W., Xu, Q., Huang, D., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0957-7 · Cited by 408 · see citing works
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
Qin, S., Bi, F., Gu, S., Bai, Y., Chen, Z., Wang, Z., Ying, J., Lu, Y., Meng, Z., Pan, H., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00163 · Cited by 412 · see citing works
Clinically applicable histopathological diagnosis system for gastric cancer detection using deep learning
Song, Z., Zou, S., Zhou, W., Huang, Y., Shao, L., Yuan, J., Gou, X., Jin, W., Wang, Z., Chen, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18147-8 · Cited by 424 · see citing works
Molecular mechanisms for tumour resistance to chemotherapy
Pan, S., Li, Z., He, Z., Qiu, J., & Zhou, S. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12581 · Cited by 402 · see citing works
PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions
Xia, L., Liu, Y., & Wang, Y. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-io-s1-s05 · Cited by 393 · see citing works
Cancer incidence and mortality in China, 2015
Zhang, S., Sun, K., Zheng, R., Zeng, H., Wang, S., Chen, R., Wei, W., & He, J. (2020) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2020.12.001 · Cited by 389 · see citing works
Self-citation
Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials
Shi, D., Shi, Y., Kaseb, A. O., Qi, X., Zhang, Y., Chi, J., Lü, Q., Gao, H., Jiang, H., Wang, H., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3259 · Cited by 382 · see citing works
Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression
Zhang, J., Bai, R., Li, M., Ye, H., Wu, C. H., Wang, C., Li, S., Tan, L., Mai, D., Li, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09712-x · Cited by 381 · see citing works
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Ye, Q., Ling, S., Zheng, S., & Xu, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1043-x · Cited by 381 · see citing works
Participation and yield of a population-based colorectal cancer screening programme in China
Chen, H., Li, N., Ren, J., Feng, X., Lyu, Z., Wei, L., Li, X., Guo, L., Zheng, Z., Zou, S., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-317124 · Cited by 377 · see citing works
Self-citation
Dissecting Esophageal Squamous-Cell Carcinoma Ecosystem by Single-Cell Transcriptomic Analysis
Zhang, X., Peng, L., Luo, Y., Zhang, S., Pu, Y., Chen, Y., Guo, W., Yao, J., Shao, M., Fan, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-021-25539-x · Cited by 369 · see citing works
Self-citation
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
Wu, Y.-L., Lu, S., Cheng, Y., Zhou, C., Wang, J., Mok, T., Zhang, L., Tu, H.-Y., Wu, L., Feng, J., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.01.006 · Cited by 357 · see citing works
Systemic immune‐inflammation index, neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio can predict clinical outcomes in patients with metastatic non‐small‐cell lung cancer treated with nivolumab
Liu, J., Li, S., Zhang, S., Liu, Y., Ma, L., Zhu, J., Xin, Y., Wang, Y., Yang, C., & Cheng, Y. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22964 · Cited by 364 · see citing works
Self-citation
Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
Yang, H., Liu, H., Chen, Y., Zhu, C., Fang, W., Yu, Z., Mao, W., Xiang, J., Han, Y., Chen, Z., et al. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.2373 · Cited by 366 · see citing works
CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer
He, W., Zhang, H., Han, F., Chen, X., Lin, R., Wang, W., Qiu, H., Zhuang, Z., Liao, Q., Zhang, W., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0381 · Cited by 359 · see citing works
Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer
Bao, Y., Wang, L., Shi, L., Yun, F., Liu, X., Chen, Y., Chen, C., Ren, Y., & Jia, Y. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0162-0 · Cited by 354 · see citing works
Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities
Kashyap, B. K., Singh, V. V., Solanki, M. K., Kumar, A. K. S., Ruokolainen, J., & Kesari, K. K. (2023) · ACS Omega · doi:10.1021/acsomega.2c07840 · Cited by 358 · see citing works
The challenge of screening for early gastric cancer in China
Zong, L., Abe, M., Seto, Y., & Ji, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32226-7 · Cited by 350 · see citing works
Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis
Li, J., Li, Z., Jiang, P., Peng, M., Zhang, X., Chen, K., Liu, H., Bi, H., Liu, X., & Li, X. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0822-3 · Cited by 345 · see citing works
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
Wang, L., Tong, X., Zhou, Z., Wang, S., Lei, Z., Zhang, T., Liu, Z., Zeng, Y., Li, C., Zhao, J., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0889-7 · Cited by 344 · see citing works
Liver cancer incidence and mortality in China: Temporal trends and projections to 2030
Zheng, R., Qu, C., Zhang, S., Zeng, H., Sun, K., Gu, X., Xia, C., Yang, Z., Li, H., Wei, W., et al. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.06.01 · Cited by 341 · see citing works
Self-citation
Circular RNA-ITCH Suppresses Lung Cancer Proliferation via Inhibiting the Wnt/β-Catenin Pathway
Wan, L., Zhang, L., Fan, K., Cheng, Z., Sun, Q., & Wang, J. (2016) · BioMed Research International · doi:10.1155/2016/1579490 · Cited by 341 · see citing works
The precision prevention and therapy of HPV ‐related cervical cancer: new concepts and clinical implications
Hu, Z., & Ma, D. (2018) · Cancer Medicine · doi:10.1002/cam4.1501 · Cited by 345 · see citing works
Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p
Liu, Z., Zhou, Y., Liang, G., Ling, Y., Tan, W., Tan, L., Andrews, R., Zhong, W., Zhang, X., Song, E., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1287-1 · Cited by 336 · see citing works
Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E
Zheng, P., Luo, Q., Wang, W., Li, J., Wang, T., Wang, P., Chen, L., Zhang, P., Chen, H., Liu, Y., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0465-5 · Cited by 381 · see citing works
Efficient Semi-supervised Gross Target Volume of Nasopharyngeal Carcinoma Segmentation via Uncertainty Rectified Pyramid Consistency
Luo, X., Liao, W., Chen, J., Song, T., Chen, Y., Zhang, S., Chen, N., Wang, G., & Zhang, S. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-87196-3_30 · Cited by 335 · see citing works
Self-citation
Breast cancer heterogeneity and its implication in personalized precision therapy
Guo, L., Kong, D., Liu, J., Zhan, L., Luo, L., Zheng, W., Zheng, Q., Chen, C., & Sun, S. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00363-1 · Cited by 355 · see citing works
Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer
YiRen, H., Yu, Y., Sunwu, Y., Li, K., Xiaochun, T., Senrui, C., Chen, E., Lin, X., & Yanfan, C. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0743-3 · Cited by 337 · see citing works
Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers
Chen, L., Zhou, L., Wang, C., Han, Y., Lu, Y., Liu, J., Hu, X., Yao, T., Lin, Y., Liang, S., et al. (2019) · Advanced Materials · doi:10.1002/adma.201904997 · Cited by 337 · see citing works
Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer
Ye, L., Zhang, T., Kang, Z., Guo, G., Sun, Y., Lin, K., Huang, Q., Shi, X., Ni, Z., Ding, N., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02368 · Cited by 331 · see citing works
Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression
Pan, L., Liang, W., Fu, M., Huang, Z., Li, X., Zhang, W., Zhang, P., Qian, H., Jiang, P., Xu, W., et al. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2361-2 · Cited by 330 · see citing works
Epidemiology of lung cancer and lung cancer screening programs in China and the United States
Yang, D., Liu, Y., Bai, C., Wang, X., & Powell, C. A. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.009 · Cited by 325 · see citing works
Global trends in esophageal cancer
Malhotra, G. K., Yanala, U., Ravipati, A., Follet, M., Vijayakumar, M., & Are, C. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24592 · Cited by 323 · see citing works

Cancer incidence and mortality in China, 2015
Zhang, S., Sun, K., Zheng, R., Zeng, H., Wang, S., Chen, R., Wei, W., & He, J. (2020) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2020.12.001 · Cited by 389 · see citing works
Self-citation
The updated incidences and mortalities of major cancers in China, 2011
Chen, W., Zheng, R., Zeng, H., & Zhang, S. (2015) · 癌症：英文版 · doi:10.1186/s40880-015-0042-6 · Cited by 218 · see citing works
Self-citation
Cancer incidence and mortality in China, 2013.
Chen, W.-Q., Zheng, R.-S., Zhang, S.-W., Zeng, H., Xia, C., Zuo, T.-T., Yang, Z.-X., Zou, X., & He, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.024 · Cited by 403 · see citing works
Self-citation
Cancer incidence and mortality in China, 2016
Zheng, R., Sun, K., Han, B., Li, L., Chen, R., Wang, S., Li, L., Zeng, H., He, J., Wei, W., et al. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.02.002 · Cited by 1,515 · see citing works
Self-citation
The incidence and mortality of major cancers in China, 2012
Chen, W., Zheng, R., Zeng, H., & Zhang, S. (2016) · 癌症：英文版 · doi:10.1186/s40880-016-0137-8 · Cited by 355 · see citing works
Self-citation

Authors: Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J.
Affiliations: Deputy Director, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Associate Researcher, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Cancer Council Queensland (AU)
Associate Professor, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Centre international de recherche sur le cancer (FR)
American Cancer Society (US)
The University of Sydney (AU)
Director National Cancer Center Beijing China.
Corresponding author: Chen, Wanqing
ORCID: Chen, Wanqing
Zheng, Rongshou
Baade, Peter D.
Zhang, Siwei
Zeng, Hongmei
Bray, Freddie
Jemal, Ahmedin
Yu, Xue Qin
He, Jie
Venue: CA: A Cancer Journal for Clinicians
Publisher: Wiley
Published: 2016-01-25
Volume: 66
Issue: 2
Pages: 115-132
ISSN: 0007-9235 (ISSN-L)
1542-4863
DOI: 10.3322/caac.21338
OpenAlex: W2272984102
Cited by: 17,038
References: 85
Citations by year: 2026: 142 · 2025: 461 · 2024: 1006 · 2023: 1271 · 2022: 1900 · 2021: 2470 · 2020: 2710 · 2019: 2630 · 2018: 2296 · 2017: 1648 · 2016: 486 · 2015: 3
FWCI: 1269.33
Type: journal article
Language: en
Open access: gold
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: CA A Cancer Journal for Clinicians (publishedVersion)
PubMed (publishedVersion)
Griffith Research Online (submittedVersion, other-oa)
The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
Funders: National Health and Family Planning Commission of China
Ministry of Science and Technology (2014FY121100)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Keywords: cancer incidence, cancer mortality, cancer burden estimation, lung cancer, gastric cancer, esophageal cancer, liver cancer, urban-rural differences, cancer incidence trends, population-based cancer registry, cancer prevention, China
MeSH terms: Adult, Aged, China, Esophageal Neoplasms, Female, Humans, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Neoplasms, Risk Factors, Rural Population, Stomach Neoplasms, Urban Population, Incidence, Prevalence, Survival Rate, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer statistics in China, 2015

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks